Teladoc Health Inc (NYSE:TDOC) price on current trading day, rose 1.19% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $8.49.
A look at the stock’s price movement, the close in the last trading session was $8.39, moving within a range at $8.3 and $8.575. The beta value (5-Year monthly) was 1.272. Turning to its 52-week performance, $15.68 and $6.76 were the 52-week high and 52-week low respectively. Overall, TDOC moved -35.24% over the past month.
Teladoc Health Inc’s market cap currently stands at around $1.47 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-25.
Analysts have a consensus estimate of 619.38M for the company’s revenue for the quarter, with a low and high estimate of 609M and 626.77M respectively. The average forecast suggests down to a -4.14% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 2.52B, representing a -1.93% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that TDOC is a 50% Sell. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
19 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 10 analyst(s) rate the stock as a Hold, 9 recommend TDOC as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Hold which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
TDOC’s current price about -11.88% and -18.47% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 36.13, while 7-day volatility ratio is 4.38% and 7.43% in the 30-day chart. Further, Teladoc Health Inc (TDOC) has a beta value of 1.72, and an average true range (ATR) of 0.70. Analysts have given the company’s stock an average 52-week price target of $11, forecast between a low of $9 and high of $13. Looking at the price targets, the low is -6.01% off current price level while to achieve the yearly target high, price needs to move -53.12%. Nonetheless, investors will most likely welcome a -29.56% jump to $11 which is the analysts’ median price.
If we refocus on Teladoc Health Inc (NYSE:TDOC), historical trading data shows that trading volumes averaged 6.98 over the past 10 days and 7.57 million over the past 3 months. The company’s latest data on shares outstanding shows there are 173.41 million shares.
The 1.00% of Teladoc Health Inc’s shares are in the hands of company insiders while institutional holders own 73.78% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 25.02 million on 2025-02-28, giving us a short ratio of 2.22. The data shows that as of 2025-02-28 short interest in Teladoc Health Inc (TDOC) stood at 1864.0 of shares outstanding, with shares short rising to 22.93 million registered in 2025-01-31. Current price change has pushed the stock -6.60% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TDOC stock continues to rise going into the next quarter.
